Wilbur James

Chief Commercial Officer10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Nov 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$150K
Net Open-Market Flow
-$150K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Sell(S)3K$43.34$150K83K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000367) within minutes of acceptance. Every field above traces to the original document. Verify it directly: